Hong Kong Jockey Club Global Health Institute to bolster global preparedness for future pandemics

The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...

November 17, 2023 | Friday | News
New typhoid conjugate vaccine Bio-TCV receives approval in Indonesia

South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...

November 14, 2023 | Tuesday | News
US FDA approves first chikungunya vaccine Ixchiq developed by Austria's Valneva

The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...

November 10, 2023 | Friday | News
Hilleman Lab invest $20M to launch new ACES cGMP Facility in Singapore

On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...

November 9, 2023 | Thursday | Company results
UK injects £33 M to develop vaccines for diseases with epidemic potential in LMICs

Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...

November 9, 2023 | Thursday | News
The Netherlands bolsters pandemic preparedness with increased funding

The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...

November 7, 2023 | Tuesday | News
Korea's SK Bioscience to boost vaccine manufacturing in Africa

South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...

November 6, 2023 | Monday | News
Korea organises training programme for African vaccine manufacturing players

South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...

November 1, 2023 | Wednesday | News
CEPI to harness Moderna’s mRNA platform for vaccine development against viral disease outbreaks

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...

October 30, 2023 | Monday | News
World-first trial by Australia to test efficacy of Strep A and rheumatic heart disease vaccine

Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...

October 25, 2023 | Wednesday | News
Reinforcing healthcare equity, access, and resilience by fine-tuning the pharma supply chain in ASEAN market

As the world is progressively rebounding from pandemic impact, Moderna is constantly developing next-generation combinat...

October 19, 2023 | Thursday | Opinion
Australia’s Doherty Institute joins CEPI to speed up pandemic vaccines development

The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...

October 20, 2023 | Friday | News
Vaccine production workforce training programme to enhance APAC's pandemic-response capacity

The Ministry of Health and Welfare in South Korea has announced that the Ministry and the Asian Development Bank (ADB) a...

October 17, 2023 | Tuesday | News
Singapore explores genetic glycoengineering to advance vaccines & therapeutics technology

A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...

October 17, 2023 | Tuesday | News
GSK and Zhifei announce exclusive strategic vaccine partnership in China

British pharmaceutical firm GlaxoSmithKline (GSK) has reached an exclusive agreement with Chongqing Zhifei Biologic...

October 13, 2023 | Friday | News
Gates Foundation to accelerate mRNA vaccine innovation in Africa and globally

At the recently held 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundati...

October 13, 2023 | Friday | News
Japan's GHIT joins hands with Institut Pasteur de Dakar in Africa to develop new diagnostics & vaccines

The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, and the Institut Pasteur de Dakar (IPD...

October 16, 2023 | Monday | News
China to support localised vaccine production in Zimbabwe and Africa

Dr Deckster Tonny SAVADYE, CEO of Zimbabwe National Biotechnology Authority (NBA), and Dr Yang Yili, Internati...

October 11, 2023 | Wednesday | News